NCT07094204 - A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors | Biotech Hunter

Enrollment

364

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

April 30, 2029

Conditions

Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal AdenocarcinomaColorectal Cancer

Interventions

DRUG

ASP5834

Intravenous infusion

DRUG

panitumumab

Intravenous infusion

Trial Locations (4)

RECRUITING

NEXT Oncology Virginia, Fairfax

RECRUITING

START Midwest, Grand Rapids

RECRUITING

NEXT Oncology Dallas, Irving

RECRUITING

Hackensack University Medical Center, Hackensack